Recent studies have shown that apoptin inhibits Bcr-Abl1 kinases in chronic myeloid leukemia (CML), and regulates the activity of protein kinase C (PKC) in myeloma cell lines, respectively [39, 40]. The gene discussed is PRRT2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.